Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.7.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 131,052 $ 168,733
Accounts receivable, net 238,893 220,284
Inventory, net 47,492 47,228
Other current assets and prepaid expenses 42,495 47,356
Total current assets 459,932 483,601
Property, plant and equipment, net 126,256 122,831
Intangible assets, net 746,654 763,976
In-process research and development 645,058 644,713
Goodwill 705,990 704,603
Investments 37,285 41,139
Other assets 38,893 5,756
Total assets 2,760,068 2,766,619
Current liabilities:    
Accounts payable 74,558 53,360
Accrued expenses 178,866 197,955
Current portion of lines of credit and notes payable 11,527 11,981
Total current liabilities 264,951 263,296
2033 Senior Notes and estimated fair value of embedded derivatives, net of discount 39,285 43,701
Deferred tax liabilities, net 159,286 165,331
Other long-term liabilities, principally deferred revenue and line of credit 189,576 202,483
Total long-term liabilities 388,147 411,515
Total liabilities 653,098 674,811
Equity:    
Common Stock - $0.01 par value, 750,000,000 shares authorized; 559,597,843 and 558,576,051 shares issued at March 31, 2017 and December 31, 2016, respectively 5,596 5,586
Treasury Stock - 586,760 shares at March 31, 2017 and December 31, 2016 (1,911) (1,911)
Additional paid-in capital 2,856,645 2,845,096
Accumulated other comprehensive loss (24,953) (27,009)
Accumulated deficit (728,407) (729,954)
Total shareholders’ equity 2,106,970 2,091,808
Total liabilities and equity $ 2,760,068 $ 2,766,619